PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC: A biomolecular exploratory, phase II trial

This is a phase II study of PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with locally advanced or borderline resectable pancreatic cancer (LAPC or BRPC, respectively). Twenty-nine patients are enrolled in the study. The objective response rate (ORR) is 60%, and the R0 re...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Juan, Lu, Changchang, Mao, Liang, Zhu, Yahui, Kong, Weiwei, Shen, Shanshan, Tang, Min, Bao, Shanhua, Cheng, Hao, Li, Gang, Chen, Jun, Li, Qi, He, Jian, Li, Aimei, Qiu, Xin, Gu, Qing, Chen, Dongsheng, Qi, Chuang, Song, Yunjie, Qian, Xiaoping, Wang, Lei, Qiu, Yudong, Liu, Baorui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040412/
https://www.ncbi.nlm.nih.gov/pubmed/36889321
http://dx.doi.org/10.1016/j.xcrm.2023.100972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040412/
https://www.ncbi.nlm.nih.gov/pubmed/36889321
http://dx.doi.org/10.1016/j.xcrm.2023.100972

Ejemplares similares